August 1, 1981Neurology
Neuroleptic Malignant syndrome caused by dopamine‐depleting drugs in a patient with Huntington disease
Population
1 patient with Huntington disease
Design
Case_report
Authors
Discussion
Loading...
Member takes
Implication
May warrant caution with dopamine-depleting agents in Huntington disease; hypothesis-generating for dopamine depletion in neuroleptic malignant syndrome pathogenesis.
Structured PICO
P
Population
1 patient with Huntington disease
I
Intervention
Dopamine-depleting agents
O
Outcome
Development of neuroleptic malignant syndrome (NMS)safety
Dopamine-depleting agents can cause neuroleptic malignant syndrome, suggesting that dopamine depletion plays a pathogenetic role in this syndrome.
Cite This Study
Burke et al. (1981) studied this question.